Nucleome raises £37.5m to shine light on ‘dark genome’
pharmaphorum
OCTOBER 19, 2022
Oxford-based Nucleome – which is developing an atlas of the dark genome and is focusing initially on finding drugs for autoimmune diseases – notes that the region contains 90% of disease-associated genetic changes, including autoimmune disorders like multiple sclerosis, lupus, and rheumatoid arthritis. Dr Danuta Jeziorska.
Let's personalize your content